Endocannabinoid Research Group, Reproductive Sciences Section, Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE2 7LX, United Kingdom.
J Clin Endocrinol Metab. 2012 Aug;97(8):2827-35. doi: 10.1210/jc.2012-1780. Epub 2012 Jun 14.
Ectopic pregnancy is associated with significant morbidity and mortality, but the molecular mechanisms underlying this condition remain unclear. Although the endocannabinoids, N-arachidonoylethanolamine (anandamide), N-oleoylethanolamine, and N-palmitoylethanolamine, are thought to play a negative role in ectopic pregnancy, their precise role(s) within the fallopian tube remains unclear. Anandamide activates cannabinoid receptors (CB1 and CB2) and, together with its degrading [e.g. fatty acid amide hydrolase (FAAH)] and synthesizing enzymes (e.g. N-acyl-phosphatidylethanolamine-specific phospholipase D), forms the endocannabinoid system. High anandamide levels are associated with tubal arrest of embryos in mice and may have a similar role in women.
The aims were to quantify the levels of the endocannabinoids and evaluate the expression of the modulating enzymes and the cannabinoid receptors in fallopian tubes of women with ectopic pregnancy compared to those of nonpregnant women.
We conducted a prospective study at the University Hospitals of the Leicester National Health Service Trust.
Fallopian tubes collected from women with ectopic pregnancy and nonpregnant women with regular menstrual cycles were used for quantification of endocannabinoids by ultra-HPLC tandem mass spectrometry, were fixed in formalin for immunohistochemistry, and had RNA extracted for RT-quantitative PCR or protein extracted for immunoblotting.
Anandamide, but not N-oleoylethanolamine and N-palmitoylethanolamine, levels were significantly higher in ectopic fallopian tubes. Endocannabinoid levels from isthmus to ampulla were not significantly different. Cannabinoid receptors and endocannabinoid modulating enzymes were localized in fallopian tube epithelium by immunohistochemistry and showed reduced CB1 and FAAH expression in ectopic pregnancy.
High anandamide levels and reduced expression of CB1 and FAAH may play a role in ectopic implantation.
宫外孕与显著的发病率和死亡率有关,但导致这种情况的分子机制仍不清楚。尽管内源性大麻素,N-花生四烯酸乙醇胺(花生四烯酸乙醇胺)、N-油酰乙醇胺和 N-棕榈酰乙醇胺,被认为在宫外孕中起负作用,但它们在输卵管中的确切作用尚不清楚。花生四烯酸乙醇胺激活大麻素受体(CB1 和 CB2),并与降解酶(如脂肪酸酰胺水解酶(FAAH))和合成酶(如 N-酰基-磷酸乙醇胺特异性磷脂酶 D)一起形成内源性大麻素系统。高花生四烯酸乙醇胺水平与小鼠胚胎在输卵管中的停滞有关,在女性中可能也有类似作用。
定量测定内源性大麻素水平,并评估与非妊娠妇女相比,宫外孕妇女输卵管中调节酶和大麻素受体的表达。
我们在莱斯特国民保健服务信托大学医院进行了一项前瞻性研究。
从宫外孕妇女和有规律月经周期的非妊娠妇女收集输卵管,通过超高效液相色谱串联质谱法定量内源性大麻素,用福尔马林固定进行免疫组织化学,提取 RNA 进行 RT-定量 PCR 或提取蛋白质进行免疫印迹。
宫外孕输卵管中花生四烯酸乙醇胺水平显著升高,但 N-油酰乙醇胺和 N-棕榈酰乙醇胺水平没有显著升高。从输卵管峡部到壶腹部的内源性大麻素水平没有显著差异。免疫组织化学显示,大麻素受体和内源性大麻素调节酶定位于输卵管上皮,宫外孕中 CB1 和 FAAH 的表达减少。
高花生四烯酸乙醇胺水平和 CB1 和 FAAH 表达减少可能在宫外孕着床中起作用。